Quick Answer
HAEMONETICS CORP reported Operating Income Loss of $221.82 million for the year ending 2025.
- HAEMONETICS CORP showed an increase of +34.5% in Operating Income Loss from 2024 to 2025.
- This data is from HAEMONETICS CORP's annual report (Form 10-K), filed with the SEC on May 21, 2025.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), HAEMONETICS CORP's Operating Income Loss has grown by 159.2%.
- Historical annual values: Fiscal year 2025: $221.82 million | Fiscal year 2024: $164.88 million | Fiscal year 2023: $156.03 million | Fiscal year 2022: $80.75 million | Fiscal year 2021: $89.75 million | Fiscal year 2020: $103.35 million | Fiscal year 2019: $83.55 million | Fiscal year 2018: $56.16 million | Fiscal year 2017: -$19.38 million | Fiscal year 2016: -$43.94 million | Fiscal year 2015: $40.54 million | Fiscal year 2014: $46.43 million | Fiscal year 2013: $56.44 million | Fiscal year 2012: $88.76 million | Fiscal year 2011: $110.55 million | Fiscal year 2010: $83.28 million | Fiscal year 2009: $85.57 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: